Mobile C-arm wins FDA clearance

Article

The Axiom Artis U developed by Siemens Medical Solutions is being prepped for entry into the U.S. market. The compact, mobile digital C-arm system, which has cleared the FDA, offers four times more generator power than any commercial mobile C-arm system,

The Axiom Artis U developed by Siemens Medical Solutions is being prepped for entry into the U.S. market. The compact, mobile digital C-arm system, which has cleared the FDA, offers four times more generator power than any commercial mobile C-arm system, according to the company. It supports a wide variety of examinations, including angiographic and cardiac interventions. The increased power supports the assessment of obese patients and provides longer fluoroscopy times. The system incorporates Siemens' CARE (combined application to reduce exposure), which automatically adjusts x-ray dose to match the density of the region of interest.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.